1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Coala-Life Group AB (publ)

Coala-Life Group AB (publ)

COALA.ST
Coala-Life Group AB (publ)SE flagStockholm Stock Exchange
0.02
SEK
+0.00
- -
24.89MMarket Cap
Coala-Life Group AB (publ)
COALA.ST
(Stockholm Stock Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2020
2021
2022
TTM
FRC
24,379.88
12,322.56
7,896.71
7,464.35
7,217.02
2,612.43
874.67
974.7
991.56
1,011.29
1,021.34
1,042.4
273.4
0.51
0.29
0.11
0.15
Revenue per Share
449.87
-2,546.54
74.7
-1,120.45
-850.51
-844.27
-73.47
19.3
11.8
13.88
16.63
-65.52
-66.65
-8.3
-10.79
-0.91
-0.46
Basic EPS, GAAP
34.11
-566.31
204.04
-298.97
-249.53
-127.73
-2.7
33.58
29.12
23.27
4.73
22.41
37.3
-8.89
-4.37
-0.88
-0.26
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
3.87
3.87
4.64
- -
- -
- -
- -
- -
- -
Dividend per Share
-43.71
-1,993.89
-1,134.44
-2,224.89
-3,136.28
-2,421.9
-896.4
-877.1
-869.18
-859.16
-847.17
-919.37
-369.99
3.51
-6.37
-0.68
- -
Book Value per Share
-4,004.48
-1,509.06
-139.01
-202.4
-612.78
-125.01
-66.22
-46.59
-45.27
-40.8
-26.26
-69.48
-49.61
2.51
3.32
-0.02
-0.02
Tangible Book Value per Share
- -
- -
- -
- -
- -
1
2
2
2
2
2
2
7
7
14
156
326
Basic Weighted Avg Shares
3,426
3,207
3,055
2,966
2,791
1,945
1,917
2,136
2,173
2,216
2,238
2,267
1,784
3
4
17
49
Sales/Revenue/Turnover
1.08
-4.24
1.57
-2.64
-3.65
-5.1
0.01
1.89
1.47
2.72
2.01
-2.01
-8.69
-1,629.48
-4,030.8
-843.04
-281.33
Operating Margin (%)
101
100
92
96
87
204
44
48
52
47
42
47
304
1
5
5
10
Depreciation Expense
63
-663
29
-445
-329
-629
-161
42
26
30
36
-142
-435
-54
-151
-142
-149
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
6.91
5.94
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
1.85
-20.67
0.95
-15.01
-11.78
-32.32
-8.4
1.98
1.19
1.37
1.63
-6.29
-24.38
-1,612.03
-3,714.1
-846.55
-303.73
Profit Margin (%)
-72
1
370
244
136
159
157
190
190
229
270
178
52
14
42
-10
-13
Working Capital
- -
- -
- -
10
22
14
403
386
402
399
419
420
1,069
1
1
3
2
LT Debt
1,404
1,071
1,405
959
628
428
266
306
323
340
389
235
-133
23
52
39
40
Total Equity
- -
- -
- -
- -
- -
- -
- -
5.71
- -
7.37
5.13
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
-3.46
- -
-4.06
-4.3
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
374
374
481
Market Capitalization
73
83
67

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
69
45
47
Cash, Cash Equivalents & STI
34
3
12
Accounts Receivable, Net
24
32
22
Inventories
10
11
12
Total Current Liabilities
41
51
59
Payables & Accruals
- -
- -
- -
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-20.71%
-41.93%
-24.85%
Free Cash Flow
-77.4%
155.16%
125.1%
Net Income, GAAP
-40.27%
-40.14%
-5.83%
Sales/Revenue/Turnover
22.88%
42.82%
313.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
1
61
1
1
4
2022
1
2
5
9
17
2023
12
14
14
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
15.59
-2.04
-3.34
-10.79
2022
-0.38
-0.24
-0.17
- -
-0.91
2023
-0.19
-0.08
-0.07
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
PROCEPT BioRobotics Corporation (PRCT)
Picard Medical, Inc. (PMI)
Geratherm Medical AG (GME.DE)
Venus Medtech (Hangzhou) Inc. (VMTHF)
Erika Carmel-Tech Ltd (ERKA.TA)
Medical Supply International USA, Inc. (MSIU)
Business
Coala-Life Group AB (publ) Coala-Life Group AB (publ) is a Sweden-based medical technology company focused on cardiac diagnostics and mobile health, developing patented products and services for digital remote monitoring, analysis, and screening of the heart and lungs. The company offers the Coala Heart Monitor, a smartphone-connected medical device and FDA-cleared, CE-approved platform enabling long-term ECG monitoring, heart sound auscultation, algorithm-based detection of atrial fibrillation and arrhythmias, and real-time feedback to patients; the Coala Care portal, a cloud-based solution for healthcare providers to prescribe, manage, communicate with patients remotely, interpret data, and generate diagnostic reports; and managed remote patient monitoring (RPM) services primarily for chronic cardiac conditions in everyday settings. It targets healthcare providers such as clinics and hospitals, with operations centered in the United States via subsidiary Coala Life Inc. in California—accounting for the majority of revenue—and presences in Europe; founded in 2015 and headquartered in Stockholm, Sweden. In recent major developments, Coala-Life Group AB (publ) filed for bankruptcy on March 22, 2024, following liquidity challenges and unsuccessful funding efforts, leading to delisting from Nasdaq First North on April 8, 2024; thereafter, PMD Device Solutions acquired key assets including the US subsidiary, intellectual property portfolio, and technology for 3.6 MSEK in April 2024 to integrate into its respiratory monitoring operations and accelerate US market entry, with post-acquisition post-market support provided by Coala Solutions AB.